New Barbie with type 1 diabetes could help kids with the condition feel seen - and help others learn
Mattel's first Barbie with type 1 diabetes.
Photo:
Mattel
Barbie has done many things since she first appeared
in 1959
. She's been an astronaut, a doctor, a president and even a palaeontologist. Now, in 2025, Barbie is something else: a woman
with type 1 diabetes
.
Mattel's latest Barbie was recently launched by
Lila Moss
, a British model who lives with type 1 diabetes. The doll comes with a visible insulin pump and a continuous glucose monitor, devices many people with diabetes rely on.
To some people, this might seem like just another version of the doll. But to kids living with type 1 diabetes - especially young girls - it's a big deal. This new Barbie is not just a toy. It's about being seen.
Mattel has introduced its first Barbie with Type 1 diabetes, as part of wider efforts from the toy maker to increase inclusivity among its dolls.
Mattel says it partnered with Type 1 diabetes advocates to ensure that the design of the doll 'truly captures the community.'
pic.twitter.com/6lfpzPbD4v
Type 1 diabetes
is a condition where the body stops making insulin, the hormone that helps control blood sugar levels.
It's not caused by lifestyle or diet. It's an
autoimmune condition
(a disorder where the immune system mistakenly attacks healthy cells) and often starts in childhood.
People with type 1 diabetes need to take insulin every day, often through multiple injections or an insulin pump. They also need to check their blood sugar regularly, using finger pricks or a continuous glucose monitor worn on the skin (usually the upper arm).
Although type 1 diabetes can be effectively managed, there is no cure.
Millions of people across the world live with this condition, and numbers are on the rise. In Australia, type 1 diabetes affects more than
13,000 children and teens
, while in New Zealand, around
2500 children under 18 have type 1 diabetes
. Globally,
1.8 million young people
are affected.
Children with type 1 diabetes may wear a continuous glucose monitor.
Photo:
Pavel Danilyuk/Pexels
Young people with type 1 diabetes must think about their condition every day - at school, during sports, at sleepovers and even while playing. They may have to stop what they're doing and check their blood sugar levels. It can feel isolating and frustrating.
Stigma is a big issue
for children and young people with type 1 diabetes
. Some young people feel embarrassed using their insulin pumps or checking their blood sugar in public. One study found
pre-teens with diabetes
sometimes felt they received unwanted attention when using devices such as insulin pumps and glucose monitors.
Stigma can make young people less likely to
take care of their diabetes
, which can
create problems
for their health.
Seeing a Barbie with an insulin pump and glucose monitor could make a significant difference.
Children form their sense of identity early, and toys play
a surprisingly powerful role
in that process. While children with type 1 diabetes can often feel different from their peers, toys can help normalise their experience and reduce the sense of isolation that can come with managing a chronic condition.
Research shows toys and media such as
books and TV shows reflecting children's experiences
can boost self-esteem, reduce stigma and
improve emotional wellbeing
.
For girls especially, Barbie is more than a doll. She represents what is often perceived to be
admired or desirable
and this can influence how girls perceive their own bodies. A Barbie with a glucose monitor and insulin pump sends a clear message: this is part of real life. You're not alone.
That kind of visibility is empowering. It tells children their condition doesn't define them or limit their potential. It also helps challenge outdated stereotypes about illness and disability.
Some may worry a doll with a medical condition might make playtime too serious or scary. But in reality, play is
how kids learn
about the world. Toys that reflect real life - including health issues -
can help children
process emotions, ask questions, reduce fear and feel more in control.
Mattel's new Barbie shows diabetes and the devices needed to manage the condition in a positive, everyday way, and that matters. It can start conversations and help kids without diabetes learn what those devices are and why someone wears them. It builds understanding early.
Mattel has added to its range of Barbies in recent years to showcase the beauty that everyone has. There are now Barbies with a wide range of skin tones, hair textures, body types and disabilities - including
dolls with hearing aids
, vitiligo (loss of skin pigmentation) and wheelchairs. The diabetes Barbie is part of this broader shift toward inclusivity and should be applauded.
Every child should be able to find toys that reflect who they are, and the people they love.
This Barbie won't make diabetes go away. But she might help a child feel more seen, more confident, more like their peers. She might help a classmate understand that a glucose monitor isn't scary - it's just something some people need. She might make a school nurse's job easier when explaining to teachers or students how to support a student with diabetes.
Living with type 1 diabetes
as a child is tough
. Anything that helps kids feel a little more included, and a little less different, is worth celebrating. A doll might seem small. But to the right child, at the right moment, it could mean everything.
* Lynne Chepulis, Associate Professor, Health Sciences, University of Waikato; Anna Serlachius, Associate Professor, Psychological Medicine, University of Auckland, Waipapa Taumata Rau
- This story originally appeared on The Conversation.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

RNZ News
8 minutes ago
- RNZ News
Is there confusion over the role of 'physician associates'?
An investigation ordered by the UK government into physician associates there has found they shouldn't diagnose and treat untriaged patients. It also recommends changing their name to "assistant" rather than associate to stop them being confused with doctors. Four months ago the Health Minister, Simeon Brown, gave the go ahead for Physician Associates to become part of the regulated health workforce here. At the moment the PA's working here are trained in the UK or the US and work under the licence of a supervising doctor. The New Zealand Resident Doctors' Association has backed the two main findings of the UK report, but the New Zealand Physicians Associate Society says the situation in the UK isn't applicable here. Kathryn is joined by Deborah Powell the National Secretary of the Resident Doctors Association and Lisa deWolfe the regulation chair of the New Zealand Physician Associate Society. To embed this content on your own webpage, cut and paste the following: See terms of use.


NZ Herald
20 hours ago
- NZ Herald
UK battles anti-vax misinformation after child's death
One British influencer, Ellie Grey, who has more than 200,000 followers on Instagram, posted a video denying that the child died from measles. 'Measles isn't this deadly disease ... it's not dangerous,' she said. Grey criticised Alder Hey for posting a video 'really, really pushing and manipulating parents into getting the MMR vaccine'. Her video was reposted by another British influencer, Kate Shemirani, a struck-off ex-nurse who posts health conspiracy theories. 'No vaccine has ever been proven safe and no vaccine has ever been proven effective,' Shemirani claimed falsely. Liverpool's public health chief Matthew Ashton attacked those 'spreading misinformation and disinformation about childhood immunisations' in the Echo newspaper, saying 'they need to take a very long, hard look at themselves'. 'For those of you that don't know, measles is a really nasty virus,' he said in a video, adding that the jab is a way of 'protecting yourself and your loved ones'. Alder Hey said it has treated 17 children with measles since June. It posted a video in which a paediatric infectious diseases consultant, Andrew McArdle, addresses measles 'myths', including that the MMR jab causes autism. This false claim comes from a debunked 1998 study by a British doctor, Andrew Wakefield, who was later struck off. But it sparked an international slump in vaccinations. 'Lingering questions' Benjamin Kasstan-Dabush, a medical anthropologist at the London School of Hygiene and Tropical Medicine, told AFP there are still 'lingering questions around the Wakefield era'. He talked to parents who had delayed vaccinating their children, finding reasons included life events and difficulty getting health appointments, but also misinformation. 'We're obviously talking about a different generation of parents, who might be engaging with that Wakefield legacy through social media, through the internet, and of course through Kennedy,' he said. US President Donald Trump appointed Robert F. Kennedy jnr as Health Secretary despite his promotion of anti-vaccine conspiracy theories. Kennedy fired all 17 experts on a key vaccine advisory panel and appointed a scientist who warned against Covid jabs. In the US, 'misinformation is being produced in the highest echelons of the Trump Administration', which 'circulates across the internet', Kasstan-Dabush said. In a sign of how narratives spread, a Telegram group airing conspiracies called Liverpool TPR, which has around 2000 members, regularly posts links to anti-vaccine group Children's Health Defence, once chaired by Kennedy. In the past few weeks, the UK Health Security Agency has amplified its social media coverage on vaccinations, a spokesman said. In a video in response to the reported death, Vanessa Saliba, a consultant epidemiologist, explained that the MMR jab protects others, including those 'receiving treatment like chemotherapy that can weaken or wipe out their immunity'. Take-up of the MMR jab needs to be 95% for herd immunity, according to the World Health Organisation. The UK has never hit this target. In Liverpool, uptake for both doses is only around 74% and below 50% in some areas, according to Ashton, while the UK rate is 84%. After Wakefield's autism claims, confirmed measles cases topped 2000 in England and Wales in 2012 before dropping. But last year, cases soared again. The same trend is happening in other countries. Europe last year reported the highest number of cases in over 25 years; the US has recorded its worst measles epidemic in over 30 years. Canada, which officially eradicated measles in 1998, has registered more than 3500 cases this year. An Ontario infectious diseases doctor, Alon Vaisman, told AFP: 'You're fighting against the wall of disinformation and lies'. -Agence France-Presse


Otago Daily Times
3 days ago
- Otago Daily Times
Wine brand ahead with Irish cancer warning
|By Guyon Espiner of RNZ One of New Zealand's most celebrated wine brands is putting cancer warning labels on wines exported to Ireland - nearly a year ahead of a law making the labels compulsory from May 2026. Villa Maria wines sold in Ireland feature a label on the bottle warning drinkers ''there is a direct link between alcohol and fatal cancers'' and also that ''drinking alcohol causes liver disease''. Alcohol harm reduction advocates say the labels should also be on alcohol sold in New Zealand rather than leaving drinkers in the dark about the cancer risk. Simon Limmer, chief executive of Indevin which owns the Villa Maria brand, said cancer warnings were on all Villa Maria wines produced for the Irish market from the 2024 vintage onwards and had been appearing on shelves over the last six months. The wine travelled long distances and could spend weeks in shipping containers and distribution before reaching retail shelves so acting early would avoid disruption for retail partners and consumers. "Consumers will likely take note of the new labels in Ireland as it's a significant change across all alcoholic products but it's too soon to understand the ongoing impact on purchasing decisions." Photos of Villa Maria wines featuring the warning labels were sent to advocacy groups in New Zealand by Alcohol Action Ireland, as it rallies support to stave off an alcohol industry lobbying effort to stall the labels. Sheila Gilheany, chief executive of Alcohol Action Ireland, wrote to alcohol harm reduction groups in New Zealand warning of a "severe threat to Ireland's alcohol health information labelling regulations". Gilheany told RNZ that Ireland's alcohol industry had opposed the cancer warning labels and was now using fears about trade tariffs to call for a delay. Irish media now expect the government to defer the introduction of cancer warning labels until 2029. Gilheany welcomed Villa Maria's acceptance of Ireland's labelling law and said winemakers from Australia and Spain had also been early adopters. "They are assuming that the government is not going to turn its back on its own law. Why should it? But at the same time, we can see the pressure that the various sectors of the industry are placing on the government here in Ireland and seeking to have it postponed." Ireland had about 1000 alcohol-related cancers every year and one in eight breast cancer cases were linked to alcohol but awareness of those risks was low, she said. Governments had to "face down the lobbying" both locally and internationally, Gilheany said. "We know that when Ireland goes ahead with this measure, particularly around the cancer warnings, it is likely that other nations will follow suit." Global push for warning labels Dozens of health groups recently wrote to British Prime Minister Sir Keir Starmer urging him to follow Ireland's lead. The letter was coordinated by the World Cancer Research Fund (WCRF) which is calling for "clear, plain, distinct and mandatory" cancer warning labels rather than ambiguous language such as "drink responsibly". In January this year, the US surgeon general said alcohol was a leading preventable cause of cancer and alcohol products should carry a warning label like cigarettes do. Virginia Nicholls, executive director of the New Zealand Alcohol Beverages Council, said the industry did not support cancer warning labels. "The level of health risk associated with alcohol is more complicated than a label can convey. "Labelling does not take into account the difference between responsible and hazardous drinking. The best place to get information on any health concerns is from your doctor." Labels may raise awareness but did not change behaviour and called for policies to "target the minority of people who are hazardous drinkers and not the large majority of Kiwis who are responsible drinkers". Nicholls said cancer risk was low when drinking at "moderate levels" and claimed there were "benefits of moderate alcohol consumption" including reduced risk of heart attacks, ischaemic strokes and diabetes. But in a 2023 statement the World Health Organisation said "when it comes to alcohol consumption, there is no safe amount that does not affect health". "There are no studies that would demonstrate that the potential beneficial effects of light and moderate drinking on cardiovascular diseases and type 2 diabetes outweigh the cancer risk associated with these same levels of alcohol consumption for individual consumers." The WHO says alcohol was classified as a Group 1 carcinogen by the International Agency for Research on Cancer decades ago. "This is the highest risk group, which also includes asbestos, radiation and tobacco." Lisa Te Morenga, co-chair of Health Coalition Aotearoa, said New Zealanders were being kept in the dark. "Most New Zealanders don't really realise that alcohol is a carcinogen. So while the Irish are having their awareness raised, our consumers are missing out." ACT's Nicole McKee, the Minister responsible for alcohol policy, is working on reform of the Sale and Supply of Alcohol Act. She said her focus was on "regulatory relief" to make business easier for retailers and hospitality venues and also on reducing alcohol-related harm. "I have not yet received any advice regarding cancer warning labels on alcohol products. Cabinet has yet to make any decisions regarding any reforms."